Mizuho Cuts Molina Healthcare (NYSE:MOH) Price Target to $330.00

Molina Healthcare (NYSE:MOH - Free Report) had its target price reduced by Mizuho from $400.00 to $330.00 in a research note released on Friday morning,Benzinga reports. They currently have an outperform rating on the stock.

MOH has been the topic of a number of other research reports. Barclays cut their price objective on shares of Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating on the stock in a research report on Monday, June 9th. Guggenheim started coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Robert W. Baird restated a "neutral" rating and issued a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Wall Street Zen downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Finally, Truist Financial upped their target price on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Eleven analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $352.21.

Molina Healthcare Stock Down 3.3%

MOH traded down $7.58 during trading on Friday, hitting $221.00. The company had a trading volume of 1,445,598 shares, compared to its average volume of 717,880. The company has a market capitalization of $11.98 billion, a PE ratio of 10.67, a PEG ratio of 0.96 and a beta of 0.55. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.87. Molina Healthcare has a one year low of $219.72 and a one year high of $365.23. The firm's 50-day moving average price is $293.27 and its 200 day moving average price is $303.24.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. The company had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The company's quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the previous year, the company posted $5.73 earnings per share. As a group, equities analysts expect that Molina Healthcare will post 24.4 earnings per share for the current year.

Insider Buying and Selling

In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director owned 11,244 shares of the company's stock, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer directly owned 257,715 shares in the company, valued at $82,484,262.90. The trade was a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Molina Healthcare

Several hedge funds have recently bought and sold shares of the stock. Farther Finance Advisors LLC lifted its holdings in Molina Healthcare by 100.3% during the 1st quarter. Farther Finance Advisors LLC now owns 659 shares of the company's stock worth $216,000 after purchasing an additional 330 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in shares of Molina Healthcare during the first quarter worth $2,759,000. Raymond James Financial Inc. bought a new stake in shares of Molina Healthcare in the fourth quarter valued at about $10,725,000. Robeco Institutional Asset Management B.V. acquired a new position in shares of Molina Healthcare in the first quarter valued at about $1,070,000. Finally, Wealth Enhancement Advisory Services LLC increased its position in Molina Healthcare by 82.1% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,635 shares of the company's stock worth $5,150,000 after acquiring an additional 7,051 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.